Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
Clinical trial NCT01534897 · COMPLETED
Trial details
- NCT number
- NCT01534897
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.